Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

被引：0
|
作者：
Hye-Jeong Choi
Yonghyuk Lee
Susin Park
Nam Kyung Je
机构：
[1] Pusan National University,College of Pharmacy
[2] Woosuk University,College of Pharmacy
来源：
European Journal of Clinical Pharmacology | 2023年 / 79卷
关键词：
Atrial fibrillation; Percutaneous coronary intervention; Triple antithrombotic therapy; Dual antithrombotic therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：541 / 551
页数：10
相关论文
共 50 条
  • [1] Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Choi, Hye-Jeong
    Lee, Yonghyuk
    Park, Susin
    Je, Nam Kyung
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (04) : 541 - 551
  • [2] Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Kerneis, Mathieu
    Talib, Usama
    Nafee, Tarek
    Daaboul, Yazan
    Pahlavani, Seyedmandi
    Pitliya, Anmol
    Furgan, M. M.
    Datta, Sudarshana
    Kazmi, Hassan A.
    Younes, Ahmed
    Gibson, C. Michael
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 524 - 530
  • [3] Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint
    Gwyn, Jennifer C. V.
    Thomas, Mark R.
    Kirchhof, Paulus
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017, 3 (03) : 157 - 162
  • [4] The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Fanaroff, Alexander C.
    Lopes, Renato D.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 69 : 11 - 17
  • [5] Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Saito, Yuichi
    Kobayashi, Yoshio
    [J]. CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2020, 35 (01) : 44 - 51
  • [6] Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Yuichi Saito
    Yoshio Kobayashi
    [J]. Cardiovascular Intervention and Therapeutics, 2020, 35 : 44 - 51
  • [7] Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Saito, Yuichi
    Kobayashi, Yoshio
    [J]. JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 1 - 6
  • [8] Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Camaj, Anton
    Miller, Michael S.
    Halperin, Jonathan L.
    Giustino, Gennaro
    [J]. CARDIOLOGY CLINICS, 2020, 38 (04) : 551 - 561
  • [9] Outcomes of Rivaroxaban as Part of Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
    Alshahrani, Asma
    Alshareef, Hanan
    Alanazi, Zaid
    Alsawaq, Enas
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (05): : 917 - 922
  • [10] Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: not a matter of faith
    Galli, Mattia
    Andreotti, Felicita
    D'Amario, Domenico
    Crea, Filippo
    Porto, Italo
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E16 - E17
12345